2016-04-19 Editorial Advisory Group Face-to-face Meeting

•  Attendance sheet to be circulated to collect attendee names

• Approve minutes

• TMO to invite KCA to present the VA RxNorm project to the drug modeling group.
• Check with Danish folks to determine the value of additional modeling of strength-related products -TMO

• Shift of responsibilities and future direction

Summary of discussion comments and review of prior decision on selection of preferred option

• from IGR - Can we have an idea of the extent of changes that will be required on current content?
• From IGR - What will it mean for project where there is usage of content that currently represent a lateralised concept?
• Add quality assurance section
• Clarify the advantages when moving to nested DL of selecting ""Laterality" in relationship group over creating Lateralized anatomy. - GRE, YGA
• Document development of technical implementation and communication plan

• Guidelines for modeling combined disorder patterns
• Addition of during, during AND/OR after to associated with role hierarchy
• Syndromes in which constituent conditions are variably present

ECE update spring IHTSDO business meeting_draft.pptx

Content tracker dashboard

IHTSDO-858 - artf6279-definition of grouper, whitelisting of exceptions to MRCM rules in User Guide ACCEPTED  

IHTSDO-908 - artf221357-Extended (non-ASCII) UTF8 characters in terms ACCEPTED

IHTSDO-512 - artf6196-Moving between hierarchies without retirement: policy ACCEPTED

IHTSDO-803 - artf6195-Word order variants: policy OPEN

IHTSDO-707 - artf222830-Editorial policy issue - "AND" vs. "AND/OR" ACCEPTED 

IHTSDO-608 - artf6253-Imperatives ACCEPTED

• Determine prioritization recommendation to assist Consultant terminologist group in selecting high impact issues.

• Develop next steps

• Clinical use as synonym for "Lymph node enlargement" and current SNOMED CT structure.

Review of continuing need for monthly meetings

Time and day verification

• Plus any topic from earlier in the meeting that need additional discussion time

• Create slide with three bullet points summarizing AG activity at the meeting